{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraisinghealth.simplecast.com%2Fepisodes%2Fcarolyn-bertozzi-lytac-wT8OEVZl","width":444,"version":"1.0","type":"rich","title":"Journal Club: Degrading Drugs for Problematic Proteins","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/8bfdd457-9cd9-4577-bbed-a027587c6960/103ea12d-dd5b-4ef8-b398-ddf54dfbe24e/cover-art-3000x3000-no-grain-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/99a121b2-ef8c-49b8-a494-bef1f41b5d15\" height=\"200\" width=\"100%\" title=\"Journal Club: Degrading Drugs for Problematic Proteins\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode of the Bio Eats World Journal Club we discuss breakthrough research developing a brand new type of drug that can target specific disease-related proteins for degradation by the cell. These new drugs could be used to attack the proteins that cause some of our most intractable diseases."}